Glucagon-like peptide-1 (GLP-1) agonists are a class of medications utilized to treat type 2 diabetes mellitus (T2DM) and obesity. This course offers a comprehensive exploration of the relationship between GLP-1 receptor agonists and ocular health including emerging evidence on their impact on ocular conditions, such as diabetic retinopathy, nonarteritic ischemic optic neuropathy, and glaucoma.